The total return over the past 12 months is -61.36% vs. +16.94% for the S&P 500. So far it's up -57.14% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (61.78%) | (14.89%) | (38.46%) | (54.05%) | (62.39%) | N/A |
| Total Return CAGR | (61.36%) | (14.50%) | (38.25%) | (53.96%) | (62.34%) | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | +14.89% | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
CervoMed Inc. (CRVO)
| Year | Start price | End price | CRVO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $7.90 | $3.31 | (57.14%) | +14.51% | (71.65%) |
| 2025 | $2.34 | $7.90 | +250.00% | +17.72% | +232.28% |
| 2024 | $7.63 | $2.34 | (70.59%) | +24.89% | (95.48%) |
| 2023 | $7.59 | $7.63 | 0.00% | +26.19% | (26.19%) |
| 2022 | $23.25 | $7.59 | (66.99%) | (18.17%) | (48.82%) |
| 2021 | $60.00 | $23.25 | (61.42%) | +28.74% | (90.16%) |
| 2020 | $34.50 | $60.00 | +74.51% | +18.37% | +56.14% |
| 2019 | $149.25 | $34.50 | (76.92%) | +31.22% | (108.14%) |
| 2018 | $1,327.50 | $149.25 | (88.76%) | (4.56%) | (84.20%) |
| 2017 | $2,542.50 | $1,327.50 | (47.79%) | +21.70% | (69.49%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
